• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recip

tetano

Editor, Senior Moderator
Cell Rep


. 2021 Jul 23;109504.
doi: 10.1016/j.celrep.2021.109504. Online ahead of print.
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients


Cristina Bergamaschi[SUP] 1 [/SUP], Evangelos Terpos[SUP] 2 [/SUP], Margherita Rosati[SUP] 3 [/SUP], Matthew Angel[SUP] 4 [/SUP], Jenifer Bear[SUP] 1 [/SUP], Dimitris Stellas[SUP] 3 [/SUP], Sevasti Karaliota[SUP] 5 [/SUP], Filia Apostolakou[SUP] 6 [/SUP], Tina Bagratuni[SUP] 2 [/SUP], Dimitris Patseas[SUP] 2 [/SUP], Sentiljana Gumeni[SUP] 7 [/SUP], Ioannis P Trougakos[SUP] 7 [/SUP], Meletios A Dimopoulos[SUP] 2 [/SUP], Barbara K Felber[SUP] 8 [/SUP], George N Pavlakis[SUP] 9 [/SUP]



Affiliations

Abstract

Early responses to vaccination are important for shaping both humoral and cellular protective immunity. Dissecting innate vaccine signatures may predict immunogenicity to help optimize the efficacy of mRNA and other vaccine strategies. Here, we characterize the cytokine and chemokine responses to the 1[SUP]st[/SUP] and 2[SUP]nd[/SUP] dose of the BNT162b2 mRNA (Pfizer/BioNtech) vaccine in antigen-naive and in previously coronavirus disease 2019 (COVID-19)-infected individuals (NCT04743388). Transient increases in interleukin-15 (IL-15) and interferon gamma (IFN-γ) levels early after boost correlate with Spike antibody levels, supporting their use as biomarkers of effective humoral immunity development in response to vaccination. We identify a systemic signature including increases in IL-15, IFN-γ, and IP-10/CXCL10 after the 1[SUP]st[/SUP] vaccination, which were enriched by tumor necrosis factor alpha (TNF-α) and IL-6 after the 2[SUP]nd[/SUP] vaccination. In previously COVID-19-infected individuals, a single vaccination results in both strong cytokine induction and antibody titers similar to the ones observed upon booster vaccination in antigen-naive individuals, a result with potential implication for future public health recommendations.

Keywords: IFN-γ; IL-15; IP10/CXCL10; SARS-CoV-2; Spike antibody; cytokines; innate immunity; mRNA vaccine.
 
Back
Top Bottom